BioRestorative Therapies, Inc. (BRTX)
1.54
-0.21
(-12.00%)
USD |
NASDAQ |
Oct 13, 16:00
1.52
-0.02
(-1.30%)
After-Hours: 20:00
BioRestorative Therapies Free Cash Flow : -11.90M for March 31, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2026 | -11.90M |
| December 31, 2025 | -10.91M |
| September 30, 2025 | -10.77M |
| June 30, 2025 | -9.627M |
| March 31, 2025 | -8.834M |
| December 31, 2024 | -8.336M |
| September 30, 2024 | -7.634M |
| June 30, 2024 | -7.068M |
| March 31, 2024 | -6.480M |
| December 31, 2023 | -6.601M |
| September 30, 2023 | -6.734M |
| June 30, 2023 | -6.970M |
| March 31, 2023 | -7.046M |
| December 31, 2022 | -6.311M |
| September 30, 2022 | -5.696M |
| June 30, 2022 | -4.898M |
| March 31, 2022 | -4.251M |
| December 31, 2021 | -3.361M |
| September 30, 2021 | -2.757M |
| June 30, 2021 | -2.651M |
| March 31, 2021 | -2.329M |
| December 31, 2020 | -1.964M |
| September 30, 2020 | -3.203M |
| June 30, 2020 | -4.397M |
| March 31, 2020 | -5.423M |
| Date | Value |
|---|---|
| December 31, 2019 | -6.954M |
| September 30, 2019 | -6.696M |
| June 30, 2019 | -6.333M |
| March 31, 2019 | -5.940M |
| December 31, 2018 | -5.118M |
| September 30, 2018 | -4.928M |
| June 30, 2018 | -4.084M |
| March 31, 2018 | -3.797M |
| December 31, 2017 | -3.857M |
| September 30, 2017 | -3.562M |
| June 30, 2017 | -4.290M |
| March 31, 2017 | -4.603M |
| December 31, 2016 | -5.192M |
| September 30, 2016 | -5.225M |
| June 30, 2016 | -4.780M |
| March 31, 2016 | -4.571M |
| December 31, 2015 | -3.605M |
| September 30, 2015 | -3.305M |
| June 30, 2015 | -2.952M |
| March 31, 2015 | -3.096M |
| December 31, 2014 | -3.228M |
| September 30, 2014 | -3.357M |
| June 30, 2014 | -2.969M |
| March 31, 2014 | -2.719M |
| December 31, 2013 | -2.684M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Myriad Genetics, Inc. | -14.20M |
| CareDx, Inc. | 84.03M |
| Natera, Inc. | 51.20M |
| Exagen, Inc. | -7.588M |
| Sera Prognostics, Inc. | -28.18M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.808M |
| Cash from Investing (Quarterly) | 0.9684M |
| Cash from Financing (Quarterly) | 4.441M |
| Free Cash Flow Per Share (Quarterly) | -4.296 |
| Free Cash Flow to Equity (Quarterly) | -3.699M |
| Free Cash Flow to Firm (Quarterly) | -3.808M |
| Free Cash Flow Yield | -1.39K% |